Tetrahydrobiisoquinoline derivatives by reaction of dopamine with glyoxal: A novel potential degenerative pathway of catecholamines under oxidative stress conditions

Chemical Research in Toxicology

Volumn 17, Issue 9, 2004, Pages 1190-1198

  Manini, Paola ^a   Panzella, Lucia ^a   Tedesco, Idolo ^b   Petitto, Fabio ^b   Russo, Gian Luigi ^b   Napolitano, Alessandra ^a   Palumbo, Anna ^c   D'Ischia, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DOPAMINE; GLYOXAL; SALSOLINOL; TETRAHYDROBIISOQUINOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CYCLIZATION; DOPAMINE METABOLISM; METHYLATION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; RAT; TOXICITY TESTING;

ANIMALS; DOPAMINE; GLYOXAL; ISOMERISM; KINETICS; OXIDATIVE STRESS; PC12 CELLS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROISOQUINOLINES; TOXICITY TESTS;

ANIMALIA;

EID: 4644309089     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx034268q     Document Type: Article

References (61)

1. Blakely, R. D. (2001) Neurobiology. Dopamine's reversal of fortune. Science 293, 2407-2409.
2. Olanow, C. W. (1990) Oxidation reaction in Parkinson's disease. Neurology 40, 32-37.
3. Fhan, S., and Cohen, G. (1992) The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann. Neurol. 32, 804-812.
4. Jones, D. C., Gunasekar, P. G., Borowitz, J. L., and Isom, G. E. (2000) Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J. Neurochem. 74, 2296-2304.
5. Maresca, V., Roccella, M., Roccella, F., Camera, E., Del Porto, G., Passi, S., Grammatico, P., and Picardo, M. (1997) Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J. Invest. Dermatol. 109, 310-313.
6. Cucchi, M. L., Frattini, P., Santagostino, G., Preda, S., and Orecchia, G. (2003) Catecholamines increase in the urine of nonsegmental vitiligo especially during its active phase. Pigm. Cell Res. 16, 111-116.
7. Dell'Anna, M. L., Urbanelli, S., Mastrofrancesco, A., Camera, E., Iacovelli, P., Leone, G., Manini, P., d'Ischia, M., and Picardo, M. (2003) Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients. Pigm. Cell Res. 16, 553-559.
8. Slivka, A., and Cohen, G. (1985) Hydroxyl radical attack on dopamine. J. Biol. Chem. 29, 15466-15472.
9. 2 oxidation of dopamine. J. Med. Chem. 38, 917-922.
10. Pezzella, A., d'Ischia, M., Napolitano, A., Misuraca, G., and Prota, G. (1997) Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: A possible contributory mechanism for neuronal degeneration in Parkinson's disease. J. Med. Chem. 40, 2211-2216.
11. Napolitano, A., Pezzella, A., and Prota, G. (1999) New reaction pathways of dopamine under oxidative stress conditions: Non-enzymatic iron-assisted conversion to norepinephrine and the neurotoxins 6-hydroxydopamine and 6,7-dihydroxyisoquinoline. Chem. Res. Taxicol. 12, 1090-1097.
12. Dryhurst, G., Shen, X.-M., Li, H., Han, J., Yang, Z., and Cheng, F.-C. (2000) The chemistry of Parkinson's disease. In Biomedical Chemistry, Applying Chemical Principles to the Understanding and Treatment of Disease (Torrence, P. F., Ed.) pp 311-346, John Wiley and Sons, New York.
13. Li, H., and Dryhurst, G. (2001) Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex. J. Neural Transm. 108, 1363-1374.
14. Spencer, J. P., Whiteman, M., Jenner, P., and Halliwell, B. (2002) 5-S-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J. Neurochem. 81, 122-129.
15. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol. 13, 135-160.
16. Daveu, C., Servy, C., Dendane, M., Marin, P., and Ducrocq, C. (1997) Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide. Nitric Oxide 1, 234-243.
17. Nappi, A. J., and Vass, E. (2001) The effects of nitric oxide on the oxidations of L-dopa and dopamine mediated by tyrosinase and peroxidase. J. Biol. Chem. 276, 11214-11222.
18. Palumbo, A., Napolitano, A., and d'Ischia, M. (2002) Nitrocatechols versus nitrocatecholamines as novel competitive inhibitors of neuronal nitric oxide synthase: lack of the aminoethyl side chain determines loss of tetrahydrobiopterin-antagonizing properties. Bioorg. Med. Chem. Lett. 12, 13-16.
19. d'Ischia, M., and Costantini, C. (1995) Nitric oxide-induced nitration of catecholamine neurotransmitters: A key to neuronal degeneration? Bioorg. Med. Chem. 3, 923-927.
20. Palumbo, A., Napolitano, A., Carraturo, A., Russo, G. L., and d'Ischia, M. (2001) Oxidative conversion of 6-nitrocatecholamines to nitrosating products: A possible contributory factor in nitric oxide and catecholamine neurotoxicity associated with oxidative stress and acidosis. Chem. Res. Toxicol. 14, 1296-1305.
21. Palumbo, A., Napolitano, A., Barone, P., and d'Ischia, M. (1999) Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-Nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration. Chem. Res. Toxicol. 12, 1213-1222.
22. de la Breteche, M. L., Servy, C., Lenfant, M., and Ducrocq, C. (1994) Nitration of catecholamines with nitrogen oxides in mild conditions. Tetrahedron Lett. 35, 7231-7232.
23. Palumbo, A., Astarita, G., and d'Ischia, M. (2001) Inhibition of neuronal nitric oxide synthase by 6-nitrocatecholamines, putative reaction products of nitric oxide with catecholamines under oxidative stress conditions. Biochem. J. 356, 105-110.
24. Thornalley, P. J., Langborg, A., and Minhas, H. S. (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344, 109-116.
25. Murata-Kamiya, N., Kamiya, H., Iwamoto, N., and Kasai, H. (1995) Formation of a mutagen, glyoxal, from DNA treated with oxygen free radicals. Carcinogenesis 16, 2251-2253.
26. Nishiyama, T., Hagiwara, Y., Hagiwara, H., and Shibamoto, T. (1994) Inhibitory effect of 2″-O-glycosyl isovitexin and alpha-tocopherol on genotoxic glyoxal formation in a lipid peroxidation system. Food Chem. Toxicol. 32, 1047-1051.
27. Niwa, H., Takeda, A., Wakai, M., Miyata, T., Yasuda, Y., Mitsuma, T., Kurokawa, K., and Sobue, G. (1998) Accelerated formation of N-epsilon- (carboxymethyl)-lysine an advanced glycation end product by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. Biochem. Biophys. Res. Commun. 248, 93-97.
28. Thornalley, P. J. (1990) The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem. J. 269, 1-11.
29. Jimbow, K., Chen, H., Park, J. S., and Thomas, P. D. (2001) Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br. J. Dermatol. 144, 55-65.
30. Fahn, S. (1992) In The Scientific Basis for the Treatment of Parkinson's Disease (Olanow, C. W., and Lieberman, A. N., Eds.) Vol. 89, p 111, Parthenon Publishing Group, Cornforth, United Kingdom.
31. Szent-Gyorgyi, A., and McLaughlin, J. (1975) Interaction of glyoxal and methylglyoxal with biogenic amines. Proc. Natl. Acad. Sci. U.S.A. 72, 1610-1611.
32. Whaley, W. M., and Govindachari, T. R. (1951) The Pictet-Spengler synthesis of tetrahydroisoquinolines and related compounds. In Organic Reactions (Adams, R., Ed.) Vol. VI, pp 151-190, John Wiley and Sons, New York.
33. Yamanaka, Y., Walsh, M. J., and Davis, V. E. (1970) Salsolinol, an alkaloid derivative of dopamine formed in vitro during alcohol metabolism. Nature 227, 1143-1144.
34. Sandler, M., Bonham Carter, S., Hunter, K. R., and Stern, G. (1973) Tetrahydroisoquinoline alkaloids: In vivo metabolites of L-DOPA in man. Nature 241, 439-443.
35. Manini, P., d'Ischia, M., Lanzetta, R., Parrilli, M., and Prota, G. (1999) Reaction of dopamine with D-glyceraldehyde under biomimetic conditions: Stereoselective formation of tetrahydroisoquinolines and rate-accelerating effects of transition metal ions. Bioorg. Med. Chem. 7, 2525-2530.
36. 2+ ions as possible implications for the origin of the therapeutic side effects. Bioorg. Med. Chem. 9, 923-929.
37. Manini, P., d'Ischia, M., and Prota, G. (2001) An unusual decarboxylative Maillard reaction between L-DOPA and D-glucose under biomimetic conditions: factors governing competition with Pictet-Spengler condensation. J. Org. Chem. 66, 5048-5053.
38. Greene, L. A., and Tischler, A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73, 2424-2428.
39. Russo, G. L., De Nisco, E., Fiore, G., Di Donato, P., d'Ischia, M., and Palumbo, A. (2003) Toxicity of melanin-free ink of Sepia officinalis to transformed cell lines: identification of the active factor as tyrosinase. Biochem. Biophys. Res. Commun. 308, 293-299.
40. Von Siegfried, M. A., Hilpert, H., Rey, M., and Dreiding, A. S. (1980) Oxidative aryl-aryl-verknupfung von 6,6′,7,7′-tetramethoxy-1, 1′,2,2′,3,3′,4,4′-octahydro-1,1′-biisochinolin- derivaten. Helv. Chim. Acta 63, 938-961.
41. Zhang, F., and Dryhurst, G. (1993) Oxidation chemistry of the endogenous central nervous system alkaloid salsolinol-1-carboxylic acid. J. Med. Chem. 36, 11-20.
42. Hafelinger, G., and Mack, H. G. (1994) Enamines: General and theoretical aspects. In The Chemistry of Functional Groups. The Chemistry of Enamines (Rapport, Z., Ed.) Part 1, p 69, John Wiley and Sons, New York.
43. Sandorfy, C. (1970) General and theoretical aspects. In The Chemistry of Functional Groups. The Chemistry of the Carbon-Nitrogen Double Bond (Patai, S., Ed.) p 37, John Wiley and Sons, New York.
44. Marchand, S., de Revel, G., and Bertrand, A. (2000) Approaches to wine aroma: Release of aroma compounds from reactions between cysteine and carbonyl compounds in wine. J. Agric. Food Chem. 48, 4890-4895.
45. Wells-Knecht, K. J., Zyzak, D. V., Litchfield, J. E., Thorpre, S. R., and Baynes, J. W. (1995) Mechanism of autoxidative glycosylation: Identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34, 3702-3709.
46. Mlakar, A., Batna, A., Dudda, A., and Spiteller, G. (1996) Iron-(II) ions induced oxidation of ascorbic acid and glucose. Free Radical Res. 25, 525-539.
47. Hunt, J. V., Dean, R. T., and Wolff, S. P. (1988) Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem. J. 256, 205-212.
48. Jung, Y. J., and Surh, Y. J. (2001) Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Radical Biol. Med. 30, 1407-1417.
49. Maruyama, W., Takahashi, T., Minami, M., Takahashi, A., Dostert, P., Nagatsu, T., and Naoi, M. (1993) Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. Adv. Neurol. 60, 224-230.
50. Naoi, M., Maruyama, W., Akao, Y., Zhang, J., and Parvez, H. (2000) Apoptosis induced by an endogenous neurotoxin, N-methyl-(R)salsolinol, in dopamine neurons. Toxicology 153, 123-141.
51. Maruyama, W., Sango, K., Iwasa, K., Minami, C., Dostert, P., Kawai, M., Moriyasu, M., and Naoi, M. (2000) Dopaminergic neurotoxins, 6,7-dihydroxy-1- (3′,4′-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: Apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines. Neurosci. Lett. 291, 89-92.
52. Naoi, M., Maruyama, W., and Dostert, P. (1995) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines: Oxidation and neurotoxicity. Prog. Brain Res. 106, 227-239.
53. Abordo, E. A., Minhas, H. S., and Thornalley, P. J. (1999) Accumulation of a-oxoaldehydes during oxidative stress: A role in cytotoxicity. Biochem. Pharmacol. 58, 641-648.
54. Kametani, T., Fukumoto, K., Agui, H., Yagi, H., Kigasawa, K., Sugahara, H., Hiiragi, M., Hayasaka, T., and Ishimaru, H. (1968) Phenolic cyclisation. Part I. Novel synthesis of 1-substituted isoquinoline and spiro[cycloalkane-1, 1′-isoquinoline] derivatives and its application to the total synthesis of isoquinoline alkaloids. J. Chem. Soc. C, 112-118.
55. Yim, H. S., Kang, S. O., Hah, Y. C., Chock, P. B., and Yim, M. B. (1995) Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals. J. Biol. Chem. 270, 28228-28233.
56. Cheng, B. Y., Origitano, T. C., and Collins, M. A. (1987) Inhibition of catechol-O-methyltransferase by 6,7-dihydroxy-3,4-dihydroisoquinolines related to dopamine: demonstration using liquid chromatography and a novel substrate for O-methylation. J. Neurochem. 48, 779-786.
57. Awada, M., and Dedon, P. C. (2001) Formation of the 1,N2-glyoxal adduct of deoxyguanosine by phosphoglycolaldehyde, a product of 3′-deoxyribose oxidation in DNA. Chem. Res. Toxicol. 14, 1247-1253.
58. Manini, P., d'Ischia, M., and Prota, G. (2000) A novel octahydropyridobenzothiazepine metabolite in human urine: Biomimetic formation from the melanogen 5-S-cysteinyldopa and formaldehyde via a peculiar sulfur-controlled double Pictet-Spengler condensation. J. Org. Chem. 65, 4269-4273.
59. Kikuchi, S., Shinpo, K., Moriwaka, F., Makita, Z., Miyata, T., and Tashiro, K. (1999) Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: Synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. J. Neurosci. Res. 57, 280-289.
60. Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., and Makita, Z. (2000) Neurotoxicity of advanced glycation end-products for cultured cortical neurons. J. Neuropathol. Exp. Neurol. 59, 1094-1105.
61. Odani, H., Shinzato, T., Matsumoto, Y., Usami, J., and Maeda, K. (1999) Increase in the three α,β-dicarbonyl compounds levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 256, 89-93.